Magic mushrooms work by delivering a compound called psilocybin, which your body converts into psilocin, a chemical that mimics serotonin and binds to specific receptors in your brain. This triggers a cascade of changes in brain connectivity that produce the hallucinations, altered thinking, and emotional shifts people describe during a psychedelic experience. The whole process, from swallowing a mushroom to returning to baseline, typically lasts 4 to 6 hours.
From Mushroom to Active Compound
Psilocybin itself isn’t actually the molecule that gets you high. It’s a prodrug, meaning it needs to be broken down before it does anything. After you eat magic mushrooms, your body rapidly absorbs psilocybin through the gut and strips off a phosphate group, converting it into psilocin. This is the molecule that crosses into your brain and produces psychedelic effects.
Psilocin levels in the blood typically peak about 2 hours after eating mushrooms, though this can range from roughly 1.8 to 4 hours depending on factors like stomach contents and individual metabolism. The intensity of the experience tracks closely with how much psilocin is circulating in your blood at any given moment.
How Psilocin Changes Your Brain Chemistry
Psilocin is structurally similar to serotonin, one of the brain’s key chemical messengers. It fits into serotonin receptors the way a slightly wrong key might still turn a lock. The critical receptor is called 5-HT2A, found densely across the outer layer of the brain. PET imaging studies have confirmed that the intensity of a psychedelic experience directly correlates with how many of these receptors psilocin occupies. When researchers give people a drug that blocks 5-HT2A receptors before administering psilocybin, the psychedelic effects don’t happen, confirming this receptor is the essential trigger.
But psilocin doesn’t just activate these receptors the same way serotonin does. It stimulates them in a pattern that triggers unusual downstream signaling inside neurons, which is what leads to the dramatic shifts in perception, emotion, and thought that define the psychedelic state.
Your Brain’s Wiring Temporarily Reorganizes
One of the most striking things psilocybin does is reshape how different brain regions communicate with each other. Normally, your brain operates in fairly segregated networks, each handling different tasks. The most studied of these is the default mode network (DMN), a set of brain regions active when you’re daydreaming, thinking about yourself, or mentally time-traveling into the past or future. The DMN is sometimes described as the seat of your sense of self.
Under psilocybin, connectivity within the DMN drops sharply. The key hubs of this network decouple from each other. At the same time, connections between networks that don’t normally talk to each other increase dramatically. The brain shifts from a modular, compartmentalized state to a more globally interconnected one. This is likely why people report ego dissolution (the feeling of boundaries between self and world dissolving), synesthesia (seeing sounds or hearing colors), and the sense that ideas or perceptions are blending together in unfamiliar ways.
In people with depression, this DMN disruption persists in a subtler form for up to three weeks after a single dose, which may partly explain why the therapeutic effects outlast the drug itself.
Psilocybin Physically Rewires Neurons
Beyond the temporary changes in brain activity, psilocybin appears to cause lasting structural changes in brain cells. A study published in Neuron found that a single dose of psilocybin increased the density of dendritic spines (the tiny protrusions on neurons where they receive signals from other neurons) by about 10% in the frontal cortex. Spine heads also grew larger, meaning existing connections got physically stronger.
These structural changes appeared within 24 hours and were still present a month later. About a third of the newly formed spines remained at the 34-day mark. The growth was accompanied by measurably increased signaling between neurons, confirming these weren’t just cosmetic changes but functional new connections. Importantly, psilocybin increased the rate at which new spines formed without increasing the rate at which old ones were eliminated, resulting in a net gain of neural connections.
This burst of structural remodeling may help explain why clinical trials have found lasting improvements in depression and anxiety after just one or two psilocybin sessions. The drug doesn’t just temporarily alter mood; it may physically rebuild neural pathways that depression has weakened.
What the Experience Feels Like, by the Clock
Effects typically begin 20 to 40 minutes after eating mushrooms, as psilocybin is absorbed and converted to psilocin. The come-up phase often involves a mix of nausea, body heaviness, and the first visual distortions. By the 1 to 2 hour mark, the experience intensifies toward its peak, which is when visual hallucinations, emotional surges, and altered thinking are strongest. Psilocin reaches its maximum blood concentration around the 2-hour mark for most people.
The peak plateau lasts roughly 1 to 2 hours before a gradual descent. Most people feel close to normal by the 5 to 6 hour mark, though a sense of emotional openness or mental fatigue can linger for the rest of the day. The total duration is significantly shorter than LSD, which typically lasts 8 to 12 hours.
Potency Varies Between Mushroom Strains
Not all magic mushrooms contain the same amount of psilocybin. Even within the most commonly used species, Psilocybe cubensis, the total concentration of psilocybin and psilocin ranges from about 0.85% to 1.45% of the mushroom’s dry weight. That means one strain can be nearly twice as potent as another. Lab analysis of five common cubensis strains found total alkaloid content ranging from 0.879% (Thai Cubensis) to 1.36% (Creeper), with popular strains like B+ falling in the middle at 1.13%.
This natural variability is one reason dosing with whole mushrooms is imprecise compared to clinical settings, where researchers use synthetic psilocybin measured to the milligram. In clinical trials, a standard therapeutic dose is 25 mg of pure psilocybin, with high doses at 35 mg.
Physical Safety and Risks
Psilocybin has an unusually wide safety margin for a psychoactive drug. The estimated lethal dose is around 6 grams of pure psilocybin, roughly 1,000 times the threshold dose of 6 mg. In practical terms, that’s equivalent to about 10 kilograms of fresh mushrooms, a quantity no one could physically consume, as vomiting would occur long before toxic levels were reached. Only three deaths in the medical literature have been directly attributed to mushroom toxicity. Expert analyses have consistently rated psilocybin as the recreational substance with the lowest overall harm.
There is no evidence of organ damage, neurological deficits, or addiction potential from psilocybin use. The drug does not produce physical dependence, and tolerance builds so rapidly that taking it on consecutive days produces sharply diminished effects, which naturally discourages compulsive use.
The real risks are psychological. People with a personal or family history of psychotic disorders like schizophrenia face the most serious concern, as psilocybin can trigger or worsen psychotic episodes. Hallucinogen persisting perception disorder (HPPD), a condition where visual disturbances continue long after the drug has worn off, is rare but documented. It occurs more frequently in people with a history of psychological issues or substance misuse, though it can happen to anyone, even after a single use. Difficult experiences during the trip itself, sometimes called “bad trips,” involve intense anxiety, paranoia, or panic, and are more likely at higher doses or in uncomfortable settings.
Why Researchers Are Paying Attention
The FDA granted breakthrough therapy designation for psilocybin in treatment-resistant depression in 2018 and in major depressive disorder in 2019. This designation doesn’t mean approval; it means the FDA considers the early evidence promising enough to fast-track the review process. Clinical trials have shown significant reductions in depression symptoms after one or two guided psilocybin sessions, with effects lasting weeks to months. The combination of acute changes in brain network connectivity and longer-term structural rewiring of neurons offers a plausible biological explanation for why a single experience can produce lasting shifts in mental health.